1st Quarter - Report

VENABLE LLP for BIG CITIES HEALTH COALITION

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Tobacco TOB

FDA regulation of tobacco, nicotine, and synthetic nicotine; Banning menthol cigarettes and flavored cigars.

LobbyistCovered position, as disclosed
LAURA A HANEN —

Alcohol and Drug Abuse ALC

Substance use prevention, including naloxone, harm reduction, and Medication for Opioid Use Disorder.

LobbyistCovered position, as disclosed
LAURA A HANEN —

Contacted: Centers For Disease Control & Prevention (CDC); Office of Natl Drug Control Policy (NDCP)

Health Issues HCR

Strengthening public health infrastructure, workforce and data in preparation for the next pandemic; Tracking Pathogens Act (S. 3534); PREVENT Pandemics Act (S. 3799); Disease X Act (S. 2640); Newborn Screening Saves Lives Reauthorization Act (H.R. 482).

LobbyistCovered position, as disclosed
LAURA A HANEN —

Bills named: H.R. 482 (117th), S. 3799 (117th), S. 2640 (117th), S. 3534 (117th)

Budget/Appropriations BUD

FY 2022 and FY 2023 Labor-HHS-Education Appropriations bill; CDC funding for Advanced Molecular Detection, immunization, smoking and health, social determinants of health, violence prevention, public health preparedness, Epi and Lab capacity, data modernization initiative, climate and health, public health workforce, public health capacity and infrastructure; Teen Pregnancy Prevention Program and Adolescent and School Health program.

LobbyistCovered position, as disclosed
LAURA A HANEN —

Contacted: Centers For Disease Control & Prevention (CDC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.